Sebastian May-Wilson

Sebastian May-Wilson

Auto-generated profile, based on publicly available information

Sebastian May-Wilson

Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NSNick Shrine
Nick Shrine
AIAbril G. Izquierdo
Abril G. Izquierdo
JCJing Chen
Jing Chen
RPRichard Packer
Richard Packer
RHRobert J. Hall
Robert J. Hall
MTMartin D. Tobin
Martin D. Tobin
Lung-function impairment underlies chronic obstructive pulmonary disease (COPD) and predicts mortality. In the largest multi-ancestry genome-wide association meta-analysis of lung function to date, comprising 588,452 participants, we identified 1,020 independent association signals implicating 559 genes supported by ≥2 criteria from a systematic variant-to-gene mapping framework. These genes were enriched in 29 pathways. Individual variants showed heterogeneity across ancestries, age and smoking groups, and collectively as a genetic risk score showed strong association with COPD across ancestry groups. We undertook phenome-wide association studies for selected associated variants as well as trait and pathway-specific genetic risk scores to infer possible consequences of intervening in pathways underlying lung function. We highlight new putative causal variants, genes, proteins and pathways, including those targeted by existing drugs. These findings bring us closer to understanding the mechanisms underlying lung function and COPD, and should inform functional genomics experiments and potentially future COPD therapies.

29 March 2023 in Nature
Verified
Journal Article
Closed access
PDF file
YXYu Xu
Yu Xu
SRScott C. Ritchie
Scott C. Ritchie
YLYujian Liang
Yujian Liang
PTPaul Reimund Hugo Jan Timmers
Paul Reimund Hugo Jan Timmers
MPMaik Pietzner
Maik Pietzner
MIMichael Inouye
Michael Inouye

18 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSebastian May-Wilson
Sebastian May-Wilson
NMNana Matoba
Nana Matoba
KWKaitlin H. Wade
Kaitlin H. Wade
JHJouke- Jan Hottenga
Jouke- Jan Hottenga
MCMaria Pina Concas
Maria Pina Concas
NPNicola Pirastu
Nicola Pirastu
We present the results of a GWAS of food liking conducted on 161,625 participants from the UK-Biobank. Liking was assessed over 139 specific foods using a 9-point scale. Genetic correlations coupled with structural equation modelling identified a multi-level hierarchical map of food-liking with three main dimensions: “Highly-palatable”, “Acquired” and “Low-caloric”. The Highly-palatable dimension is genetically uncorrelated from the other two, suggesting that independent processes underlie liking high reward foods. This is confirmed by genetic correlations with MRI brain traits which show with distinct associations. Comparison with the corresponding food consumption traits shows a high genetic correlation, while liking exhibits twice the heritability. GWAS analysis identified 1,401 significant food-liking associations which showed substantial agreement in the direction of effects with 11 independent cohorts. In conclusion, we created a comprehensive map of the genetic determinants and associated neurophysiological factors of food-liking.

1 October 2017 in European Journal of Cancer
Verified
Journal Article
Open access
SMSebastian May-Wilson
Sebastian May-Wilson
ASAmit Sud
Amit Sud
PLPhilip J. Law
Philip J. Law
KPKimmo Palin
Kimmo Palin
STSari Tuupanen
Sari Tuupanen
Richard HoulstonRichard Houlston
Richard Houlston
While dietary fat has been established as a risk factor for colorectal cancer (CRC), associations between fatty acids (FAs) and CRC have been inconsistent. Using Mendelian randomisation (MR), we sought to evaluate associations between polyunsaturated (PUFA), monounsaturated (MUFA) and saturated FAs (SFAs) and CRC risk. We analysed genotype data on 9254 CRC cases and 18,386 controls of European ancestry. Externally weighted polygenic risk scores were generated and used to evaluate associations with CRC per one standard deviation increase in genetically defined plasma FA levels. Risk reduction was observed for oleic and palmitoleic MUFAs (OROA = 0.77, 95% CI: 0.65-0.92, P = 3.9 × 10-3; ORPOA = 0.36, 95% CI: 0.15-0.84, P = 0.018). PUFAs linoleic and arachidonic acid had negative and positive associations with CRC respectively (ORLA = 0.95, 95% CI: 0.93-0.98, P = 3.7 × 10-4; ORAA = 1.05, 95% CI: 1.02-1.07, P = 1.7 × 10-4). The SFA stearic acid was associated with increased CRC risk (ORSA = 1.17, 95% CI: 1.01-1.35, P = 0.041). Results from our analysis are broadly consistent with a pro-inflammatory FA profile having a detrimental effect in terms of CRC risk.

16 December 2020 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
JKJohn R.P. Knight
John R.P. Knight
CAConstantinos Alexandrou
Constantinos Alexandrou
GSGeorge L. Skalka
George L. Skalka
NVNikola Vlahov
Nikola Vlahov
KPKathryn Ann Foster Pennel
Kathryn Ann Foster Pennel
OSOwen Sansom
Owen Sansom
KRAS-mutant colorectal cancers are resistant to therapeutics, presenting a significant problem for ∼40% of cases. Rapalogs, which inhibit mTORC1 and thus protein synthesis, are significantly less potent in KRAS-mutant colorectal cancer. Using Kras-mutant mouse models and mouse- and patient-derived organoids, we demonstrate that KRAS with G12D mutation fundamentally rewires translation to increase both bulk and mRNA-specific translation initiation. This occurs via the MNK/eIF4E pathway culminating in sustained expression of c-MYC. By genetic and small-molecule targeting of this pathway, we acutely sensitize KRASG12D models to rapamycin via suppression of c-MYC. We show that 45% of colorectal cancers have high signaling through mTORC1 and the MNKs, with this signature correlating with a 3.5-year shorter cancer-specific survival in a subset of patients. This work provides a c-MYC–dependent cotargeting strategy with remarkable potency in multiple Kras-mutant mouse models and metastatic human organoids and identifies a patient population that may benefit from its clinical application. Significance: KRAS mutation and elevated c-MYC are widespread in many tumors but remain predominantly untargetable. We find that mutant KRAS modulates translation, culminating in increased expression of c-MYC. We describe an effective strategy targeting mTORC1 and MNK in KRAS-mutant mouse and human models, pathways that are also commonly co-upregulated in colorectal cancer. This article is highlighted in the In This Issue feature, p. 995

29 August 2024 in Nature Human Behaviour
Verified
Journal Article
Closed access
PDF file
LRLinda Repetto
Linda Repetto
JCJiantao Chen
Jiantao Chen
ZYZhijian Yang
Zhijian Yang
RZRanran Zhai
Ranran Zhai
PTPaul Reimund Hugo Jan Timmers
Paul Reimund Hugo Jan Timmers
XSXia Shen
Xia Shen